✦ LIBER ✦

Incidence and time course of thrombocytopenia with abciximab and eptifibatide in patients undergoing percutaneous coronary intervention

✍ Scribed by Ibrahim E. Fahdi; Jorge F. Saucedo; Thomas Hennebry; Mohammad Ghani; Saihari Sadanandan; Luis Garza-Arreola

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Open-label, sequential comparison of ept

✍ Marc J Schweiger; Hameem U Changezi; Deborah Naglieri-Prescod; James R Cook 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 535 KB

Time course, magnitude, and consistency

✍ Dean J Kereiakes; Thomas M Broderick; Eli M Roth; David Whang; Thomas Shimshak; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 454 KB

Bivalirudin versus heparin and eptifibat

✍ Ramona Mehrinfar; Atman Prabodh Shah 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Medical and interventional management of

✍ G. CAMPO; J. MARCHESINI; L. FILETI; M. TEBALDI; R. FERRARI 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Comparison of abciximab with “high-dose”

✍ Athula P. Gunasekara; Darren L. Walters; Con N. Aroney 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 109 KB

PCV36 USE OF ABCIXIMAB IN PATIENTS UNDER

✍ F Fillon; J Macé; N Chemali; J De Kervasdoué 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB